Mitsubishi Chemical Group has signed an agreement to sell its pharmaceutical business Mitsubishi Tanabe Pharma Corp. to Bain Capital (Boston, Massachusetts). The cost of the transaction is ¥510 billion ($3.3 billion). The closing of this transaction is scheduled for the second quarter of 2026, subject to a resolution at the annual shareholders’ meeting scheduled in June 2025.
Mitsubishi Chemical said after becoming a subsidiary in 2020, Mitsubishi Tanabe Pharma worked to create synergies between businesses through the mutual use of technology and human resources within the group, but changes in the industry and business structure have reduced the potential for synergies.
It said large-scale investment is essential to strengthen Mitsubishi Tanabe Pharma’s research and development capacity and further growth, but such investment would not be a feasible option under Mitsubishi Chemical’s ownership.
Mitsubishi Chemical projects to achieve a gain of ¥95 billion in the second quarter of 2026 due to the transaction.
Mitsubishi Chemical plans to utilize the funds obtained through the transfer to improve its financial base by reducing debt, to enhance shareholder returns and to advance the company’s growth objectives centered on the chemicals business.
Mitsubishi Chemical for the fiscal first nine months ended Dec. 31 posted a net profit of ¥59.3 billion, down by 42.8% year over year, on sales up 2.7% to ¥3.3 trillion. Operating profit dropped 10.8% year over year, to ¥189.4 billion.
by Kartik Kohli
Source: chemweek.com
Beggs joins PPG with more than 25 years of experience in financial leadership positions in public and private organizations with a focus on specialty materials and diverse end markets. Since 2020, she has served as CFO of Avient Corporation, an innovator of materials solutions. Beggs also currently serves on the Board of Directors of International Paper.
BASF’s Aroma Ingredients business unit announced the official launch of three newly built world-scale plants – menthol and Linalool in Ludwigshafen, Germany, and citral in Zhanjiang, China. This announcement follows the inauguration ceremony of BASF’s Zhanjiang Verbund site held on March 26, 2026.
Ineos will become a shareholder and an anchor customer of Sandpiper. The project represents a significant milestone in Sandpiper’s commitment to accelerating the clean energy transition and delivering competitively priced chemical feedstocks to global markets.
